Table 1 Correlations between PLA2G7 and clinicopathological characteristics of DLBCL based on TCGA database
From: Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma
Characteristics | PLA2G7 expression | P-value | |
|---|---|---|---|
High,no.cases | Low,no.cases | ||
Age (years) | |||
  ≤ 57 | 13 | 11 |  |
  > 57 | 11 | 13 | 0.564 |
Gender | |||
 Female | 11 | 15 |  |
 Male | 13 | 9 | 0.247 |
Stromal score | |||
 Low | 8 | 16 |  |
 High | 16 | 8 | 0.021 |
Immune score | |||
 Low | 7 | 17 |  |
 High | 17 | 7 | 0.004 |
Maximum tumor dimension | |||
 NA | 6 | 4 |  |
  ≤ 3 | 8 | 12 |  |
  > 3 | 10 | 8 | 0.491 |
Primary therapy outcome | |||
 NA | 1 | 4 |  |
 CR | 18 | 17 |  |
 PR | 2 | 0 |  |
 SD | 1 | 1 |  |
 PD | 2 | 2 | 0.43 |
Tumor stage | |||
 NA | 2 | 4 |  |
 I | 4 | 4 |  |
 II | 9 | 8 |  |
 III | 4 | 1 |  |
 IV | 5 | 7 | 0.552 |